Clinical trial
Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a…
NCT00464061 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00464061 |
|---|---|
| Title | Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus |
| Official title | Efficacy and Safety of 2mg/Day of M100907 on Sleep Maintenance Insomnia With a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: a One Year, Multi-center, Randomized, Double-blind, Placebo-controlled Study |
| Acronym | SAMS |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | Volinanserin, Placebo |
| Enrollment | 1,847 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 20, 2007 |
| Last update posted | May 26, 2016 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Germany, Hong Kong, India and 10 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: